News

Published on 9 Apr 2023 on Insider Monkey via Yahoo Finance

Inventiva S.A. (NASDAQ:IVA) Q4 2022 Earnings Call Transcript


Article preview image

Inventiva S.A. (NASDAQ:IVA) Q4 2022 Earnings Call Transcript March 30, 2023

Operator: Good day and thank you for standing by. Welcome to the Inventiva 2022 Full Year Results Call and Webcast. At this time, all participants are in listen-only mode. After the speakers' presentation, there will be a question-and-answer session. Please note that today's conference is being recorded. I would now like to hand over to your speaker, Mr. Frédéric Cren. Please go ahead, sir.

Frédéric Cren: Thank you, operator, and welcome to everybody to this full year 2022 financial results. As usual, I will be making with my colleagues forward-looking statements. So please have a look at the regulatory documentation that is available on our website. In terms of speakers today, I'm very happy as usual to have Pierre with us our CSO and Co-Founder; Michael, our CMO, will go through an update of our three important clinical trials with lanifibranor, of course, the Phase III, but also two Phase II that are ongoing. And then Jean will conclude the presentation with an update on the financials. Of course, at the end of the session, we will have a Q&A session. So let me give you, first of all, some highlights for the full year.

NASDAQ.IVA price evolution

Want to become a better investor?

Start tracking your investments with Statfolio

Sign up for free
Related News
Inventiva S.A. (NASDAQ:IVA) Q4 2023 Earnings Call Transcript

Inventiva S.A. (NASDAQ:IVA) Q4 2023 Earnings Call Transcript March 28, 2024 Inventiva S.A. isn't ...

Insider Monkey via Yahoo Finance 1 Apr 2024

Madrigal Pharmaceuticals Wins Approval for the First Drug Targeting the Multibillion-Dollar NASH...

Some events are so pivotal for a company that they cause everything to change. The company's worl...

Motley Fool via Yahoo Finance 20 Mar 2024

Inventiva S.A. (NASDAQ:IVA) Q4 2022 Earnings Call Transcript

Inventiva S.A. (NASDAQ:IVA) Q4 2022 Earnings Call Transcript March 30, 2023 Operator: Good day an...

Insider Monkey via Yahoo Finance 9 Apr 2023

Humana (HUM) Ups '23 Medicare Advantage Membership Growth View

Humana Inc. HUM recently raised its membership growth outlook for 2023. A better-than-expected sa...

Zacks via Yahoo Finance 2 Dec 2022

Cigna (CI) Rises 18.9% in 6 Months: More Growth in Store?

Cigna Corporation’s CI shares have jumped 18.9% in the past six months compared with the 7.7% ris...

MSN News 29 Nov 2022

Why You Should Add UnitedHealth (UNH) to Your Portfolio Now

UnitedHealth Group Incorporated UNH is well-poised to grow on the back of robust Optum and United...

Zacks via Yahoo Finance 22 Nov 2022

Teladoc (TDOC) Achieves Momentous 50M Milestone in Visits

Teladoc Health, Inc. TDOC recently announced that the company has exceeded 50 million patient vis...

Zacks via Yahoo Finance 16 Nov 2022

Teladoc (TDOC) Up 1.6% Since Q3 Earnings Beat on Higher Visits

Teladoc Health, Inc.'s TDOC shares rose 1.6% since it reported earnings on Oct 26, 2022. It repor...

Zacks via Yahoo Finance 8 Nov 2022

Why Is Community Health (CYH) Up 27.8% Despite Q3 Earnings Miss?

Community Health Systems, Inc.’s CYH shares have jumped 27.8% since it reported its third-quarter...

Zacks via Yahoo Finance 7 Nov 2022

After 10 Years Of Collaboration, AbbVie Discontinues Inventiva-Partnered Psoriasis Candidate

Inventiva (NASDAQ: IVA) said that AbbVie Inc (NYSE: ABBV) would stop developing cedirogant (ABBV-...

Benzinga via Yahoo Finance 31 Oct 2022